Zamara Mariam, Sarfaraz K. Niazi
2023.12.14Endocrinology Diabetes & Metabolism
tlooto Summary
A large number of GLP‐1RAs have emerged as promising therapeutic options for addressing Type‐2 diabetes, obesity, and related conditions and gained attention owing to their favourable pharmacological properties and clinical efficacy.
Abstract
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as promising therapeutic options for addressing Type‐2 diabetes, obesity, and related conditions. Among these, semaglutide, tirzepatide, liraglutide etc., all notable GLP‐1RA, have gained attention owing to their favourable pharmacological properties and clinical efficacy.
Citation format
MARIAM, Zamara; NIAZI, Sarfaraz K. Glucagon‐like peptide agonists: A prospective review. Endocrinology Diabetes & Metabolism, 2023, 7.